Abstract

ES04.03 Overcoming Resistance by Improving Treatment Compliance

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
L.E Hendriks ... M Reck
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 34
L.E Hendriks, et. al.L.E Hendriks ... M Reck
23 Jan 2023
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S Peters ... E Felip
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 23
S Peters, et. al.S Peters ... E Felip
01 Oct 2012
The Challenges of Third-Generation EGFR Tyrosine Kinase Inhibitors in the Therapy of Advanced NSCLC
Fen Wang ... Qing Zhou
Journal of Thoracic Oncology | VOL. 17
Fen Wang, et. al.Fen Wang ... Qing Zhou
17 Mar 2022
Novel agents in the treatment of lung cancer: conference summary statement.
Thomas J Lynch ... Rafael Rosell
Clinical cancer research : an official journal of the American Association for Cancer Research | VOL. 10
Thomas J Lynch, et. al.Thomas J Lynch ... Rafael Rosell
15 Jun 2004
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
From the IASLC Early Detection and Screening Committee Terminology Issues in Screening and Early Detection of Lung Cancer – IASLC Early Detection and Screening Committee Expert Group Recommendations
Rudolf M Huber ... Rudolf Huber
Journal of Thoracic Oncology | VOL. -
Rudolf M Huber, et. al.Rudolf M Huber ... Rudolf Huber
02 Aug 2024
Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)
David Kozono ... Mary W Redman
Journal of Thoracic Oncology | VOL. -
David Kozono, et. al.David Kozono ... Mary W Redman
01 Aug 2024
Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy
Peter S.N Van Rossum ... José S.A Belderbos
Journal of Thoracic Oncology | VOL. -
Peter S.N Van Rossum, et. al.Peter S.N Van Rossum ... José S.A Belderbos
25 Jul 2024
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
View more papers